loader
Please Wait
Applying Filters...

Polpharma European CDMO Partner & API Manufacturer since 1951 Polpharma European CDMO Partner & API Manufacturer since 1951

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Fosravuconazole, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Fosravuconazole

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    MARKET PLACE

    PharmaCompass

    Bora Pharmaceuticals- Making success more certain.

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    2D Structure
    1. Also known as: 351227-64-0, Fosravuconazole [inn], Bms-379224, Ravuconazole phosphoester, Ravuconazole methylphosphate, E1224 free acid
    Molecular Formula
    C23H20F2N5O5PS
    Molecular Weight
    547.5  g/mol
    InChI Key
    SYTNEMZCCLUTNX-NPMXOYFQSA-N
    FDA UNII
    L4Q6O5430L
    Fosravuconazole is under investigation in clinical trial NCT03378661 (BENDITA BEnznidazole New Doses Improved Treatment and Associations).
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    [(2R,3R)-3-[4-(4-cyanophenyl)-1,3-thiazol-2-yl]-2-(2,4-difluorophenyl)-1-(1,2,4-triazol-1-yl)butan-2-yl]oxymethyl dihydrogen phosphate
    2.1.2 InChI
    InChI=1S/C23H20F2N5O5PS/c1-15(22-29-21(10-37-22)17-4-2-16(9-26)3-5-17)23(11-30-13-27-12-28-30,34-14-35-36(31,32)33)19-7-6-18(24)8-20(19)25/h2-8,10,12-13,15H,11,14H2,1H3,(H2,31,32,33)/t15-,23+/m0/s1
    2.1.3 InChI Key
    SYTNEMZCCLUTNX-NPMXOYFQSA-N
    2.1.4 Canonical SMILES
    CC(C1=NC(=CS1)C2=CC=C(C=C2)C#N)C(CN3C=NC=N3)(C4=C(C=C(C=C4)F)F)OCOP(=O)(O)O
    2.1.5 Isomeric SMILES
    C[C@@H](C1=NC(=CS1)C2=CC=C(C=C2)C#N)[C@](CN3C=NC=N3)(C4=C(C=C(C=C4)F)F)OCOP(=O)(O)O
    2.2 Other Identifiers
    2.2.1 UNII
    L4Q6O5430L
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Bms-379224

    2.3.2 Depositor-Supplied Synonyms

    1. 351227-64-0

    2. Fosravuconazole [inn]

    3. Bms-379224

    4. Ravuconazole Phosphoester

    5. Ravuconazole Methylphosphate

    6. E1224 Free Acid

    7. Ravuconazole Methyl Phosphate

    8. E-1224 Free Acid

    9. Chebi:34549

    10. L4q6o5430l

    11. Bms 379224

    12. (((2r,3r)-3-(4-(4-cyanophenyl)thiazol-2-yl)-2-(2,4-difluorophenyl)-1-(1h-1,2,4-triazol-1-yl)butan-2-yl)oxy)methyl Dihydrogen Phosphate

    13. Benzonitrile, 4-(2-((1r,2r)-2-(2,4-difluorophenyl)-1-methyl-2-((phosphonooxy)methoxy)-3-(1h-1,2,4-triazol-1-yl)propyl)-4-thiazolyl)-

    14. Unii-l4q6o5430l

    15. Fosravuconazole [mi]

    16. Chembl333325

    17. Schembl1434200

    18. Fosravuconazole [who-dd]

    19. Dtxsid70188627

    20. Db15204

    21. [(2r,3r)-3-[4-(4-cyanophenyl)-1,3-thiazol-2-yl]-2-(2,4-difluorophenyl)-1-(1,2,4-triazol-1-yl)butan-2-yl]oxymethyl Dihydrogen Phosphate

    22. Hy-16779

    23. Cs-0012407

    24. Q27116141

    25. 4-[2-[(1r,2r)-1-methyl-2-(phosphonooxymethoxy)-2-(2,4-difluorophenyl)-3-(1h-1,2,4-triazole-1-yl)propyl]thiazole-4-yl]benzonitrile

    2.4 Create Date
    2006-10-25
    3 Chemical and Physical Properties
    Molecular Weight 547.5 g/mol
    Molecular Formula C23H20F2N5O5PS
    XLogP32.4
    Hydrogen Bond Donor Count2
    Hydrogen Bond Acceptor Count12
    Rotatable Bond Count10
    Exact Mass547.08908325 g/mol
    Monoisotopic Mass547.08908325 g/mol
    Topological Polar Surface Area172 Ų
    Heavy Atom Count37
    Formal Charge0
    Complexity859
    Isotope Atom Count0
    Defined Atom Stereocenter Count2
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Pharmacology and Biochemistry
    4.1 ATC Code

    D - Dermatologicals

    D01 - Antifungals for dermatological use

    D01B - Antifungals for systemic use

    D01BA - Antifungals for systemic use

    D01BA03 - Fosravuconazole

    Post Enquiry
    POST ENQUIRY